News | October 06, 2023
Ministry of Ayush to launch special campaign 3.0,
The Main campaign started from October 2
The Main campaign started from October 2
This integrated care offering is a step forward in our vision of providing an effective continuum of care for patients
This product is bioequivalent to the reference listed drug (RLD), Nexium 24 HR Delayed- Release Capsules, 2.0mg (OTC), of AstraZeneca Pharmaceuticals
The approval adds to a list of products that Strides has approved in this therapeutic category through the PEPFAR pathway taking the total to 15 products
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
The product is bioequivalent and therapeutically equivalent to the RLD, Vascepa of Amarin
Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by respiratory syncytial virus
Balaxi Healthcare Ecuador S.A.S. has become a Wholly Owned Subsidiary of the company
SigTuple’s AI100 with Shonit is the premier solution for AI assisted digital pathology
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
Subscribe To Our Newsletter & Stay Updated
